[Neoadjuvant chemotherapy for rescectable pancreatic cancer: "fashion" or necessity?]

The interest in neoadjuvant chemotherapy (NACT) for resectable ductal pancreatic cancer (PC) has increased significantly in recent years, primarily due to unsatisfactory long-term outcomes in these patients. However, oncological rationale for this ap…

Preview only. Read the full abstract at the source